Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2022 | 9/30/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,751 | – | $1,465 | -$13,997 |
| Dep. & Amort. | $53 | – | $256 | $120 |
| Deferred Tax | $1,050 | – | $0 | $48 |
| Stock-Based Comp. | $0 | – | $0 | $743 |
| Change in WC | -$394 | – | -$16,372 | -$2,157 |
| Other Non-Cash | $11 | – | $1,962 | $144 |
| Operating Cash Flow | $5,471 | – | -$12,689 | -$15,099 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | – | $0 | $0 |
| Net Acquisitions | $0 | – | $0 | $0 |
| Inv. Purchases | -$37,399 | – | $0 | $0 |
| Inv. Sales/Matur. | $0 | – | $0 | $0 |
| Other Inv. Act. | $0 | – | $0 | $0 |
| Investing Cash Flow | -$37,399 | – | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | $0 | $0 |
| Stock Issued | $0 | – | $0 | $0 |
| Stock Repurch. | $0 | – | -$13,575 | $0 |
| Dividends Paid | $0 | – | $0 | $0 |
| Other Fin. Act. | $0 | – | -$13,575 | $0 |
| Financing Cash Flow | $0 | – | -$13,575 | $0 |
| Forex Effect | $0 | – | $0 | $0 |
| Net Chg. in Cash | -$31,928 | – | -$26,136 | -$15,099 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42,650 | – | $95,028 | $110,841 |
| End Cash | $10,722 | – | $68,892 | $95,742 |
| Free Cash Flow | $5,471 | – | -$12,689 | -$15,099 |